Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4713-4720

  Shi, Ke Qing ^a   Wu, Fa Ling ^a   Liu, Wen Yue ^a   Zhao, Chen Chen ^a   Chen, Chang Xi ^a   Xie, Yao Yao ^a   Wu, Sheng Jie ^a   Lin, Xian Feng ^a,b   Chen, Yong Ping ^a   Wong, Danny Ka Ho ^c   Yuen, Man Fung ^c,d   Zheng, Ming Hua ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiography; Bare metal stent; In stent restenosis; Non alcoholic fatty liver disease

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; STAINLESS STEEL;

AGED; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; STABLE ANGINA PECTORIS; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD; COMPLICATION; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; STATISTICAL MODEL; STENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS; SEX FACTORS; STAINLESS STEEL; STENTS;

EID: 84903376072     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3342-z     Document Type: Article

References (31)

1. Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50:204-210
2. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124-131
3. David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB (2009) Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:1904-1912
4. Utzschneider KM, Kahn SE (2006) Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753-4761 (Pubitemid 44917301)
5. Kasturiratne A, Weerasinghe S, Dassanayake AS, Rajindrajith S, de Silva AP, Kato N, Wickremasinghe AR, de Silva HJ (2012) Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol 28(1):142-147
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917-923 (Pubitemid 36397405)
7. Targher G, Arcaro G (2007) Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191:235-240 (Pubitemid 46400718)
8. Bonora E, Targher G (2012) Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol 9:372-381
9. Targher G, Chonchol M, Pichiri I, Zoppini G (2011) Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? J Endocrinol Invest 34:544-551
10. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, Chim AM, Yu CM, Yu J, Chan FK et al (2011) Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60:1721-1727
11. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341-1350
12. Sun Z, Almutairi AM (2010) Diagnostic accuracy of 64 multislice CT angiography in the assessment of coronary in-stent restenosis: a meta-analysis. Eur J Radiol 73:266-273
13. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM (2000) Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35:157-163 (Pubitemid 30061274)
14. Desouza CV, Hamel FG, Bidasee K, O'Connell K (2011) Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60:1286-1294
15. Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, Zhang B, Iwata A, Nishikawa H, Kawamura A et al (2011) Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb 18:574-583
16. Obika M, Noguchi H (2012) Diagnosis and evaluation of non-alcoholic fatty liver disease. Exp Diabetes Res 2012:145754
17. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084-1089 (Pubitemid 26120185)
18. Mazeika P, Prasad N, Bui S, Seidelin PH (2003) Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 145:1013-1021 (Pubitemid 36688252)
19. Huang Y, Bi Y, Xu M, Ma Z, Xu Y, Wang T, Li M, Liu Y, Lu J, Chen Y et al (2012) Nonalcoholic Fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese. Arterioscler Thromb Vasc Biol 32:2321-2326
20. Jornayvaz FR, Samuel VT, Shulman GI (2010) The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr 30:273-290
21. Polyzos SA, Kountouras J, Deretzi G, Zavos C, Mantzoros CS (2012) The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. Curr Mol Med 12:68-82
22. Choi D, Kim SK, Choi SH, Ko YG, Ahn CW, Jang Y, Lim SK, Lee HC, Cha BS (2004) Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 27:2654-2660 (Pubitemid 39441466)
23. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792 (Pubitemid 44033298)
24. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M et al (2005) Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504 (Pubitemid 41014319)
25. Kamishirado H, Inoue T, Sakuma M, Tsuda T, Hayashi T, Takayanagi K, Node K (2007) Effects of statins on restenosis after coronary stent implantation. Angiology 58:55-60
26. Rana JS, Mittleman MA, Ho KK, Cutlip DE (2005) Obesity and clinical restenosis after coronary stent placement. Am Heart J 150:821-826 (Pubitemid 41396521)
27. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schuhlen H, Dirschinger J, Schomig A (2003) Gender and restenosis after coronary artery stenting. Eur Heart J 24:1523-1530 (Pubitemid 37010583)
28. Bernelot Moens SJ, Schnitzler GR, Nickerson M, Guo H, Ueda K, Lu Q, Aronovitz MJ, Nickerson H, Baur WE, Hansen U et al (2012) Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 126(16):1993-2004
29. Novella S, Laguna-Fernandez A, Lazaro-Franco M, Sobrino A, Bueno-Beti C, Tarin JJ, Monsalve E, Sanchis J, Hermenegildo C (2012). Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells. Mol Cell Endocrinol
30. Vavra AK, Havelka GE, Martinez J, Lee VR, Fu B, Jiang Q, Keefer LK, Kibbe MR (2011) Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia. Nitric Oxide 25:22-30
31. El-Koofy N, El-Karaksy H, El-Akel W, Helmy H, Anwar G, El-Sayed R, El-Hennawy A (2012) Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children. Eur J Radiol 81:3120-3123